← All trials
NCT05674981
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 24, 2023
- Primary completion
- Jan 31, 2024
- Completion date
- Jan 31, 2024
- First posted
- Jan 9, 2023
- Last posted
- May 15, 2023
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- GenMont Biotech IncorporationLead sponsor
- Chung Shan Medical UniversityCollaborator
- Chung Shan Medical UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.